American Journal of Psychiatry · 1974 · 158 citations · 16 references
MedicinePharmacologyPsychiatryNeurochemistryNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepressionDepression PharmacotherapyDepressive DisordersAffective Behavior ChangesAntidepressant EfficacyDepression PathophysiologyEtiology Of Mood DisordersMechanisms Of Antidepressant ActionPharmacodynamic MechanismsPsychostimulant PharmacodynamicsSerotonergic Modulation Of Mood
The authors present experimental evidence to support the hypothesis that 2-phenylethylamine (PEA) and its metabolites modulate affective behavior. Values for the urinary excretion of PEA were lower for 71 percent of a group of depressed patients than the lowest values obtained from control subjects, which suggests that a large percentage of endogenous depressions may be due to a deficit of PEA in the brain. Animal studies indicate that an increase in the levels of PEA in the brain may be partly responsible for the elation induced by marijuana and for the therapeutic action of antidepressant agents.
16
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
Goodwin Fk, Murphy Dl, Brodie Hk et al. · PubMed · 1970 · 182 citations
Medicine, Pharmacology, Psychiatry +14